64 articles, transcripts, and reports
Merck is a multinational pharmaceutical company which announced its earnings call on October 28, 2021. Merck beat Zacks consensus on EPS earning $1.54 per share.…
Merck & Co., Inc. (NYSE: MRK) Q3 2021 earnings call dated Oct. 28, 2021 Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations Robert M. Davis — Chief Executive…
Merck & Co., Inc. (NYSE: MRK) Q3 2021 Earnings Conference
Merck & Co., Inc. (NYSE: MRK) Q2 2021 earnings call dated Jul. 29, 2021 Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations Robert M. Davis — Chief Executive…
Merck & Co., Inc. (NYSE: MRK) reported earnings and sales for the second quarter of 2021. Worldwide sales edged up 22% year-over-year to $11.4 billion…
Merck & Co, inc (NYSE: MRK) Q2 2021 Earnings Conference
After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the mass production of vaccines developed…
Merck & Co., Inc. (NYSE: MRK) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations Kenneth C. Frazier — Chairman and…
Merck & Co, inc (NYSE: MRK) Q1 2021 Earnings Conference
Merck & Co Inc (NYSE: MRK) Q4 2020 earnings call dated Feb. 04, 2021 Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations Kenneth C. Frazier — Chairman of the…
